Autonomix Medical Files 8-K on Shareholder Votes
Ticker: AMIX · Form: 8-K · Filed: Oct 17, 2024 · CIK: 1617867
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, 8-k
TL;DR
Autonomix Medical filed an 8-K today regarding shareholder votes. Check for details.
AI Summary
Autonomix Medical, Inc. filed an 8-K on October 17, 2024, to report on matters submitted to a vote of its security holders. The filing details the company's corporate structure, including its state of incorporation (Delaware) and fiscal year end (March 31). It also provides contact information for the company's principal executive offices located in The Woodlands, Texas.
Why It Matters
This filing informs investors about key decisions made by Autonomix Medical's shareholders, which could impact the company's future direction and governance.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of corporate actions and does not indicate immediate financial distress or significant operational changes.
Key Numbers
- 0331 — Fiscal Year End (Indicates the end of the company's annual accounting period.)
Key Players & Entities
- Autonomix Medical, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- The Woodlands, TX (location) — Principal executive offices
FAQ
What specific matters were submitted to a vote of Autonomix Medical's security holders?
The filing states that it is a 'Submission of Matters to a Vote of Security Holders' but does not detail the specific matters in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported is dated October 17, 2024.
What is Autonomix Medical's primary business classification?
Autonomix Medical, Inc. is classified under Standard Industrial Classification code 3841, which pertains to Surgical & Medical Instruments & Apparatus.
Where are Autonomix Medical's principal executive offices located?
The principal executive offices are located at 21 Waterway Avenue, Suite 300, The Woodlands, TX 77380.
What is the SEC file number for Autonomix Medical, Inc.?
The SEC file number for Autonomix Medical, Inc. is 001-41940.
Filing Stats: 722 words · 3 min read · ~2 pages · Grade level 10.9 · Accepted 2024-10-17 17:20:27
Key Financial Figures
- $0.001 — h Registered Common Stock , par value $0.001 per share AMIX The Nasdaq Stock Mark
Filing Documents
- amix20241017_8k.htm (8-K) — 43KB
- logo.jpg (GRAPHIC) — 2KB
- 0001437749-24-031491.txt ( ) — 183KB
- amix-20241017.xsd (EX-101.SCH) — 3KB
- amix-20241017_def.xml (EX-101.DEF) — 12KB
- amix-20241017_lab.xml (EX-101.LAB) — 15KB
- amix-20241017_pre.xml (EX-101.PRE) — 12KB
- amix20241017_8k_htm.xml (XML) — 3KB
07. Submission of Matters to a Vote of Security Holders
Item 5.07. Submission of Matters to a Vote of Security Holders. On October 17, 2024, Autonomix Medical, Inc. (the "Company") held its annual meeting of stockholders (the "Annual Meeting"). The number of shares of common stock that voted on matters presented at the Annual Meeting was 17,353,091, representing approximately 75.3% of the 23,036,933 shares common stock outstanding as of the August 26, 2024, the record date for the Annual Meeting (the "Record Date"). Each director nominee was elected and each other matter submitted to a vote of the Company's stockholders at the Annual Meeting, as described below, was approved by the requisite vote of the Company's stockholders. The final voting results for each of the proposals submitted to a vote of the stockholders of the Company at the Annual Meeting are set forth below. The proposals are described in detail in the Company's Definitive Proxy Statement filed with the U.S. Securities and Exchange Commission (the "SEC") on September 4, 2024 (the "Proxy Statement") and are incorporated herein by reference. Proposal 1. To elect five Board nominees to the Board of Directors of the Company, each to serve until the 2025 annual meeting of stockholders of the Company or until such person's successor is qualified and elected. Nominee Votes For Votes Withheld Broker Non-Votes Walter V. Klemp 14,208,987 50,119 3,093,985 Lori Bisson 14,207,409 51,697 3,093,985 Jonathan P. Foster 14,153,659 105,447 3,093,985 David Robbins 14,160,402 98,704 3,093,985 Christopher Capelli 14,167,760 91,346 3,093,985 Proposal 2. To ratify the appointment of Forvis Mazars, LLP as the Company's independent registered public accounting firm for the year ending March 31, 2025. Votes For Votes Against Abstain Broker Non-Votes 16,949,691 89,582 313,817 0 Proposal 3. To approve an amendment to the Company's amended and restated certificate of incorporation to grant the Company's Board of Directors authority to effe